Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer

Informazioni relative al progetto

DEFINITIVE

ID dell’accordo di sovvenzione: 101136953

DOI

10.3030/101136953

Data della firma CE 11 Dicembre 2023

Data di avvio 1 Dicembre 2023

Data di completamento 30 Novembre 2028

Finanziato da

• Health

Costo totale

€ 7 999 930,00

Contributo UE

€ 7 999 930,00

Coordinato da

FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Spain

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (7)

Conclusions of common annual meeting of the ‘Diagnostics and Treatment (diagnostics)’ cluster -1

Report on the conclusions of common annual meeting of the ‘Dianostics and Treatment’ cluster

Clinical guidelines

Summary of developped clinical guidelines based on DEFINITIVE project results - 1

Exploring patient experience in the HER2+ DEFINITIVE clinical trial: a qualitative study

Objectives and methods that will be used to collect DEFINITIVE trial patients experience.

Quality Assurance and Risk Management Plan

Document detailing the Quality Assurance and Risk Management Plan

Plan for ethic-legal monitoring

Document detailing the plan for ethic-legal monitoring & ethical submissions.

Dissemination and Communication Plan 1

Document describing the Dissemination and Communication Plan to ensure full exploitation of the project’s outputs and results.

Clinical guidelines 2

Summary of developped clinical guidelines based on DEFINITIVE project results - 2

Data Management Plan (1)

Data Management Plan 1

Document describing the management plan for DEFINITIVE project

Websites, patent fillings, videos etc. (1)

Project dedicated public website

DEFINITIVE webpage with public and private domains